I
t is well-established both that the prevalence of diabetes mellitus (DM) is rising rapidly in the developed world and that its presence is a significant risk factor for cardiovascular disease and death (1) . Over the last decade, it also has become increasingly clear that for patients with diabetes who require coronary artery revascularization, in addition to optimal medical therapy, that the results of coronary artery bypass grafting (CABG) are superior to percutaneous coronary intervention in terms of significant reductions in mortality, myocardial infarction, and the need for repeat interventions but at the cost of a slightly increased risk of stroke (2, 3) . From the Department of Cardiac Surgery, Oxford University Hospitals Trust, Oxford, United Kingdom. Dr. Taggert has reported that he has no relationships relevant to the contents of this paper to disclose. 
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